Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (461-470 of 506) with videos related to

Pageof 51
Sort By:
Rheumatology (Oxford, England)|November 9, 2023
Heart and systemic sclerosis-findings from a national cohort studyAlexis F Guédon, Fabrice Carrat, Luc Mouthon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Musculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database studyLaetitia Houx, Eric Hachulla, Isabelle Kone-Paut, et al.
Plos One|March 23, 2016
Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with CyclophosphamideAlexandra Audemard-Verger, Nicolas Martin Silva, Céline Verstuyft, et al.
Annals of the Rheumatic Diseases|December 7, 2014
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)Raphaèle Seror, Hendrika Bootsma, Alain Saraux, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patientsMarie Jachiet, Béatrice Flageul, Alban Deroux, et al.
RMD Open|December 10, 2024
Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysisAlexis F Guédon, Fabrice Carrat, Luc Mouthon, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaisonChiara Baldini, Laurent Arnaud, Tadej Avčin, et al.
The Journal of Rheumatology|December 3, 2019
Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 PatientsRaphael Lhote, Marie Chilles, Matthieu Groh, et al.
Annals of the Rheumatic Diseases|January 18, 2026
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)Liubov Petelytska, Lorenzo Tofani, Arthiha Velauthapillai, et al.
Annals of the Rheumatic Diseases|August 17, 2012
TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patientsEugénie Koumakis, Julien Wipff, Philippe Dieudé, et al.
Pageof 51

Showing results (461-470 of 506) with videos related to

Sort By:
Pageof 51
Rheumatology (Oxford, England)|November 9, 2023
Heart and systemic sclerosis-findings from a national cohort studyAlexis F Guédon, Fabrice Carrat, Luc Mouthon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Musculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database studyLaetitia Houx, Eric Hachulla, Isabelle Kone-Paut, et al.
Plos One|March 23, 2016
Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with CyclophosphamideAlexandra Audemard-Verger, Nicolas Martin Silva, Céline Verstuyft, et al.
Annals of the Rheumatic Diseases|December 7, 2014
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)Raphaèle Seror, Hendrika Bootsma, Alain Saraux, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patientsMarie Jachiet, Béatrice Flageul, Alban Deroux, et al.
RMD Open|December 10, 2024
Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysisAlexis F Guédon, Fabrice Carrat, Luc Mouthon, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaisonChiara Baldini, Laurent Arnaud, Tadej Avčin, et al.
The Journal of Rheumatology|December 3, 2019
Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 PatientsRaphael Lhote, Marie Chilles, Matthieu Groh, et al.
Annals of the Rheumatic Diseases|January 18, 2026
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)Liubov Petelytska, Lorenzo Tofani, Arthiha Velauthapillai, et al.
Annals of the Rheumatic Diseases|August 17, 2012
TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patientsEugénie Koumakis, Julien Wipff, Philippe Dieudé, et al.
Pageof 51